几家大银行给予维拉治疗学“Buy”评级,预测股票增长超过100%。 Several major banks give Vera Therapeutics a "Buy" rating, predicting over 100% stock increase.

包括Guggenheim、Goldman Sachs、JP摩根和Wells Fargo在内的几家经纪公司对Vera治疗公司(NASDAQ:VERA)给予了正面评级并提高了价格目标,表明其潜在收益超过100%。 Several brokerage firms, including Guggenheim, Goldman Sachs, JPMorgan, and Wells Fargo, have issued positive ratings and increased price targets for Vera Therapeutics (NASDAQ:VERA), suggesting a potential upside of over 100%. 股票的平均评级是“Buy”, 一致商定价格目标为65.11美元。 The stock's average rating is "Buy" with a consensus price target of $65.11. Vera理疗公司是一家临床阶段生物技术公司,其股份在中午上升到29.05美元。 Vera Therapeutics, a clinical-stage biotech firm, has seen its shares rise midday to $29.05.